GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » EXMceuticals Inc (FRA:9OM1) » Definitions » Current Ratio

EXMceuticals (FRA:9OM1) Current Ratio : 0.22 (As of Mar. 2021)


View and export this data going back to 2015. Start your Free Trial

What is EXMceuticals Current Ratio?

The current ratio is a liquidity ratio that measures a company's ability to pay short-term obligations. It is calculated as a company's Total Current Assets divides by its Total Current Liabilities. EXMceuticals's current ratio for the quarter that ended in Mar. 2021 was 0.22.

EXMceuticals has a current ratio of 0.22. It indicates that the company may have difficulty meeting its current obligations. Low values, however, do not indicate a critical problem. If EXMceuticals has good long-term prospects, it may be able to borrow against those prospects to meet current obligations.

The historical rank and industry rank for EXMceuticals's Current Ratio or its related term are showing as below:

FRA:9OM1's Current Ratio is not ranked *
in the Drug Manufacturers industry.
Industry Median: 1.87
* Ranked among companies with meaningful Current Ratio only.

EXMceuticals Current Ratio Historical Data

The historical data trend for EXMceuticals's Current Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

EXMceuticals Current Ratio Chart

EXMceuticals Annual Data
Trend Jun11 Jun12 Jun13 Jun14 Jun15 Jun16 Jun17 Jun18 Jun19 Jun20
Current Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.20 0.07 2.27 0.35 0.04

EXMceuticals Quarterly Data
Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21
Current Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.04 0.22 0.18 0.22

Competitive Comparison of EXMceuticals's Current Ratio

For the Drug Manufacturers - Specialty & Generic subindustry, EXMceuticals's Current Ratio, along with its competitors' market caps and Current Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


EXMceuticals's Current Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, EXMceuticals's Current Ratio distribution charts can be found below:

* The bar in red indicates where EXMceuticals's Current Ratio falls into.



EXMceuticals Current Ratio Calculation

The current ratio is mainly used to give an idea of the company's ability to pay back its short-term liabilities with its short-term assets.

EXMceuticals's Current Ratio for the fiscal year that ended in Jun. 2020 is calculated as

Current Ratio (A: Jun. 2020 )=Total Current Assets (A: Jun. 2020 )/Total Current Liabilities (A: Jun. 2020 )
=0.235/5.434
=0.04

EXMceuticals's Current Ratio for the quarter that ended in Mar. 2021 is calculated as

Current Ratio (Q: Mar. 2021 )=Total Current Assets (Q: Mar. 2021 )/Total Current Liabilities (Q: Mar. 2021 )
=0.414/1.918
=0.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


EXMceuticals  (FRA:9OM1) Current Ratio Explanation

The current ratio can give a sense of the efficiency of a company's operating cycle or its ability to turn its product into cash. Companies that have trouble getting paid on their receivables or have long inventory turnover can run into liquidity problems because they are unable to alleviate their obligations. Because business operations differ in each industry, it is always more useful to compare companies within the same industry.

Acceptable current ratios vary from industry to industry and are generally between 1 and 3 for healthy businesses.

The higher the current ratio, the more capable the company is of paying its obligations. A ratio under 1 suggests that the company would be unable to pay off its obligations if they came due at that point. While this shows the company is not in good financial health, it does not necessarily mean that it will go bankrupt - as there are many ways to access financing - but it is definitely not a good sign.

If all other things were equal, a creditor, who is expecting to be paid in the next 12 months, would consider a high current ratio to be better than a low current ratio, because a high current ratio means that the company is more likely to meet its liabilities which fall due in the next 12 months.


EXMceuticals Current Ratio Related Terms

Thank you for viewing the detailed overview of EXMceuticals's Current Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


EXMceuticals (FRA:9OM1) Business Description

Traded in Other Exchanges
N/A
Address
421 7th Avenue S.W., 30th Floor, Calgary, AB, CAN, T2P 4K9
EXMceuticals Inc is a bio-science company that believes in the potential health and wellness benefits of hemp and cannabis. EXM is an emerging player in the market, with ambition and potential to become the suppliers of highest-grade cannabis ingredients. It is creating an industrial-scale, GMP, Pharmaceutical Grade Extraction and Refining facility inside the European Union, near Lisbon Portugal. It has an existing and licensed cannabis R&D facility and pilot refinery in Lisbon Portugal. EXM is targeting the B2B marketplace and will supply pure ingredients and API's to the pharmaceutical, medicinal and wellness industry.

EXMceuticals (FRA:9OM1) Headlines

No Headlines